Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Quarterly figures for Vaccinex, Inc., with source filings when available.
31 quarters. Jun 30, 2017 to Dec 31, 2024. USD.
Vaccinex, Inc. has filed its 10-Q within 44 to 46 days of period end across its last 8 quarters. The 10-K runs 69 to 105 days.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 15, 2025 | 105 d | 10-K | $213.00K | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | $52.00K | +160.0% | -$2.83 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | $232.00K | — | -$3.10 | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $104.00K | −81.1% | -$2.94 | |
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 2, 2024 | 93 d | 10-K | $0.00 | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | |||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | $0.00 | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 8, 2021 | 39 d | |||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 31, 2021 | 90 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | ||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 9, 2020 | 69 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Mar 13, 2019 | 72 d | 10-K | $194.00K | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 13, 2018 | ||||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | — | — | — | — | — | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | — | — | -$5.75 | |
| Q2 2017 | |||||||||
| 10-Q |
| $20.00K |
| −60.0% |
| -$15.25 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $0.00 | — | -$24.54 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | $550.00K | — | -$20.89 |
|---|
| $50.00K |
| ±0.0% |
| -$1.67 |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | -$0.13 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | — | — | -$0.12 |
|---|
| 10-Q |
| $50.00K |
| −92.0% |
| -$0.17 |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $0.00 | — | -$0.21 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | $850.00K | — | -$0.26 |
|---|
| $625.00K |
| +54.7% |
| -$0.44 |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | — | — | -$0.39 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 14, 2020 | 44 d | 10-Q | — | — | -$0.45 |
|---|
| 43 d |
| 10-Q |
| $404.00K |
| +104.0% |
| -$0.56 |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | $25.00K | −80.2% | -$0.77 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | $94.00K | −54.4% | -$0.79 |
|---|
| 44 d |
| 10-Q |
| $198.00K |
| — |
| -$0.93 |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $126.00K | — | -$6.72 |
|---|
| Q1 2018 | Mar 31, 2018 | — | — | — | — | $206.00K | — | -$7.13 |
|---|
| Jun 30, 2017 |
| — |
| — |
| — |
| — |
| — |
| — |
| -$5.15 |
